COMMERCIALIZATION CONNECT
NOVEMBER 2020
|
|
UKACCEL/UACCEL APPLICATION OPEN |
|
UKACCEL/UACCEL APPLICATION FOR SPRING 2021 OPEN
The application process for the spring 2021 cohort of UKAccel/UAccel is now open. If you are interested in learning how to advance your technology toward commercialization, then make sure to apply before the deadline of Friday, December 18.
The program known as UKAccel for innovators at the University of Kentucky and UAccel for innovators at Kentucky Commercialization Ventures (Eastern Kentucky University, KCTCS, Kentucky State University, Morehead State University, Murray State University, Northern Kentucky University, and Western Kentucky University) offers professional development and an experiential learning opportunity.
This program is managed by our partner Launch Blue, who will be hosting an information session via Zoom on Thursday, December 3 at 12:00 p.m. ET.
The spring cohort will run from February 19-May 9, 2021.
|
|
AUTM WOMEN INVENTORS SIG (WISIG) SURVEY OF FACULTY
WOMEN INVENTORS AND ENTREPRENEURS
There is a wonderful effort by the AUTM's WISIG who is attempting to better understand the best way to engage under-represented populations in inventing or entrepreneurship.
WISIG is conducting a survey of women faculty inventors/entrepreneurs who have been involved in innovation so to understand factors that encouraged or discouraged participation.
WISIG plans to use this knowledge to develop tools and best practices to help tech transfer offices increase participation of all members of its ecosystems. We encourage the participation of all women faculty inventors/entrepreneurs in this survey in order to share the importance of your innovator contributions.
Survey results will be collected until Friday, November 20th.
|
|
DRUG REPURPOSING SHORT COURSE |
|
 |
Drug Repurposing Short Course
Session 1 Webinar
IP STRATEGIES: CLAIMING NEW METHODS OF USE AND NEW FORMULATIONS, AND LICENSING IP
Date: November 19, 2020
Time: 11:00 a.m. ET
- Introduction to regulatory considerations for 505b2 application
- Intellectual Property (IP) considerations for drug repurposing
- Two mini case studies: new drug formulations vs new use
Presented by Gaby L. Longsworth, Ph.D., director, Sterne Kessler's Biotechnolgy & Chemical Practice Group, co-chair, Diversity Committee at Sterne Kessler, and LMG Life Sciences "Life Sciences Star", 2016-present.
|
Check out the Drug Repurposing Short Course Landing Page to learn about all the sessions. |
|
|
|
You can access Why You Need a Patent Landscape Search and all of the OTC Monthly Webinars on our YouTube Channel. Check it out now! |
|
|
PATENTS ISSUED
OCTOBER 2020
Kunlei Liu, James Landon, Ayokunle Omosebi
William L. Boatright
|
|
LICENSING DEALS
OCTOBER 2020
GreenLight Biosciences, Inc
Subba Palli
Ramesh Dhadapani
The Geneva Foundation
|
|
Every Wednesday, 8:00 a.m. - 9:00 a.m. ET
Virtual
|
Every Friday, 12:30 - 1:30 p.m. ET
Virtual
GEWLEX EVENT:
Thursday, November 19, 4:00 - 5:00 p.m. ET
Virtual
|
|
Every Wednesday, 12:00 p.m. ET
Virtual
|
Every Friday, 9:00 a.m. - 5:00 p.m. ET
Base 110, 110 W Vine St, 3rd Floor, Lexington
In person
|
GEWLEX EVENT:
Thursday, November 19, 4:00 - 5:00 p.m. ET
Virtual
|
|
|
MICHAEL ORR
OTC FELLOW ALUM
|
|
Michael Orr participated in the OTC Fellows program from January-December 2018. He is currently the healthcare project manager at the Vanderbilt Institute for Clinical and Translational Research (VICTR). Michael is developing and managing translational preclinical research and clinical trials.
1. Did being an OTC Fellow change your career trajectory? If so, how?
Certainly! As a graduate student it was easy to get tunnel vision on a project or career path. The OTC fellowship helped give me a fresh perspective on how innovations actually lead to impactful changes, and gave me a passion for facilitating research actually making a difference in the healthcare system.
2. How did being an OTC Fellow help you with your current job?
My job specifically cited my experience with the OTC as a distinguishing feature of my resume, and I actively use the intellectual property and entrepreneurial training from the OTC on a day-to-day basis as a means to better facilitate the commercialization of impactful clinical innovations.
“My OTC Fellowship was a fantastic experience, filled with wonderful new people, training, and experience! The OTC remains one of the highlights of my time in graduate school and I am lucky to carry the experience forward with me throughout my career.” -- Michael Orr
|
|
|
|
|
|
|
